Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veronorte is a prominent Colombian corporate venture capital firm that manages investment vehicles for major conglomerates Grupo SURA and Grupo Argos. The firm specializes in early-stage and growth-stage investments across the Americas, with a significant strategic focus on the healthcare, energy, and financial services sectors. In the life sciences and healthcare domain, Veronorte targets innovative health-tech solutions, medical services, and digital health platforms that align with the strategic goals of its corporate partners. By providing both capital and access to a broad corporate ecosystem, Veronorte aims to accelerate the development of transformative technologies in the Latin American market and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veronorte.